About Ypsomed
Ypsomed is a publicly listed company based in Burgdorf (Switzerland) founded in 2001, and was acquired by Techmed in April 2025. Self-injection systems and diabetes care products are developed and manufactured. Ypsomed has raised $7.45 million across 1 funding round from investors including BV Partners and TecMed Deutschland. The company has 2,640 employees. Its website ypsomed.com draws about 61 thousand monthly visits. Its Indian entity Ypsomed India Private Limited reported revenue of ₹15.47 Cr. Ypsomed offers products and services including Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump. Its focus areas include Life Sciences, Diabetes, Medical Devices and Therapeutic Devices.
Company details
Ypsomed was founded in 2001 in Burgdorf, Switzerland, where injection systems for self-medication and diabetes care products are developed and manufactured. The portfolio encompasses blood glucose monitoring systems, pen needles, safety devices, and infusion systems. Operations focus on the medical device sector, supplying tools for diabetes management and self-administration across global markets.
- Indian entity revenue₹15.47 Cr
FY 2025 · -5% YoY
- Indian entity net loss-₹6.00 Cr
FY 2025 · -39% margin
- Indian entity EBITDA-₹5.92 Cr
FY 2025 · -38% margin
- Total Equity Funding$7.45M (USD)
in 1 rounds
- Latest Funding Round$7.45M (USD), Series A
Jun 2003
- InvestorsBV Partners
& 1 more
- Employee Count2,640
- Acquired byTechmed
(Apr 2025)
Associated legal entities of Ypsomed
Ypsomed operates through Ypsomed India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ypsomed India Private Limited CIN U74120DL2007PTC170003 | Active | 31 Oct 2007 | New Delhi, Delhi | ₹15.5 Cr | 3 | View details |
Products & Services of Ypsomed
Ypsomed offers a comprehensive portfolio of products and services, including Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump.
Technologies for reliable self-medication injection devices.
Products for easy diabetes self-treatment and monitoring.
Simple insulin pump system for diabetes management.
Apps and channels of Ypsomed
its YouTube channel Ypsomed Selfcare Solutions has 1.54K subscribers and 30 videos.
Videos from Ypsomed
The most watched videos on Ypsomed's YouTube channel, Ypsomed Selfcare Solutions (1.54K subscribers). Click a video to play it here.
More on Ypsomed Selfcare Solutions.
Funding Insights of Ypsomed
Ypsomed has successfully raised a total of $7.45M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.45 million completed in June 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.45M
- Total Rounds 1
- Last Round Series A — $7.45M
- First Round $7.45M
(Jun 2003)
- Investors Count 1
All 1 funding rounds of Ypsomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2003 | $7.45M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Ypsomed
Ypsomed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BV Partners and TecMed Deutschland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Equity financing is offered by BV Partners for businesses. | bvpartners.ch | Switzerland | ||
TecMed Deutschland GmbH is focused on producing insulin pump components. | 2021 | tecmedgmbh.de | Schwerin, Germany |
Investor details for Ypsomed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ypsomed India Private Limited (Ypsomed)
Ypsomed India Private Limited is the primary company behind Ypsomed. The board of Ypsomed India Private Limited currently have 3 directors; the longest-serving is Sanjay Rajpal, appointed in 2015. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Rajpal DIN 07119927 | Director | 06 Feb 2015 | 11 yrs 9 mo | Ypsomed India Private Limited |
| Jaydeep Purujit Mehta DIN 06952808 | Director | 31 Jul 2024 | 2 yrs 3 mo | Ypsomed India Private Limited |
| Umeshbhai Arvindbhai Vyas DIN 07979266 | Director | 31 Jul 2024 | 2 yrs 3 mo | Ypsomed India Private Limited |
People of Ypsomed
143 people are tracked at Ypsomed (57 in leadership, 4 in board & advisors, 82 in team); the tracked headcount is 2,640.
| Name | Role | Group |
|---|---|---|
Frank Mengis | COO | Leadership |
Andreas Schneider | Vice President & Head Of Innovation | Leadership |
Simon Michel | CEO & Director | Leadership |
Ralf Kuenzi | Account & Business Development Manager & Director | Leadership |
Reto Jost | Category Lead, Director | Leadership |
Manuel Steiner | Associate Director, Business Intelligence Expert | Leadership |
Michael Zaugg | Chief Corporate Officer | Leadership |
Christian Schneider | CIO / Head Of Information Technology | Leadership |
Ralph M. Fasler | Vice President | Leadership |
Beat Aeschlimann | Head Of Operation Services | Leadership |
Samuel Künzli | CFO | Leadership |
Reto Falk | Manager Account & Business Development, Director | Leadership |
Nicolas Meyer | Chief Legal Officer | Leadership |
Kathy Elkins | Business Development And Product Director | Leadership |
Bernd Mahlmann | Business Development Director | Leadership |
Orfeo Niedermann | Manager Account & Business Development, Director | Leadership |
Marco Nanzer | Head Of Manufacturing | Leadership |
Patrick Reinhard | Head Of Manufacturing | Leadership |
Jakob Lange | Head Of Account & Business Development, Vice President | Leadership |
Roland S. | VP Global Supply Chain Operations | Leadership |
123 more people are available in the full profile.
Complete people profiles for Ypsomed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Ypsomed
Ypsomed is a publicly listed company on the SIX with ticker symbol YPSN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Sep 2004
- Listed onSWX: YPSN
- Listed entityYpsomed Holding AG
- Exchange sectorHealth technology
- ISINCH0019396990
- Share price296.40 CHF (+2.63% on the day) · 2026-05-11
- Market capitalisation3,936,926,382.00 CHF
- Price to earnings20.9
- EPS (diluted, trailing year)14.21 CHF
- Dividend yield0.76%
- Volume (last session)8,679
- Analyst consensusStrong buy
Financials of Ypsomed
Figures of Ypsomed India Private Limited, the primary company behind Ypsomed, for FY 2025. Revenue was ₹15.47 Cr (-5% year on year). Net loss was -₹6.00 Cr (-39% margin). EBITDA was -₹5.92 Cr (-38% margin). Revenue has grown at a compounded annual rate of +1% over three years and +8% over five years.
- ₹15.47 CrRevenue · FY 2025 · -5% YoY
- -₹6.00 CrNet loss · -39% margin
- -₹5.92 CrEBITDA · -38% margin
- ₹5.25 CrPaid-up capital
- +1%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 731.0M CHF | 221.9M CHF | 266.9M CHF |
| 2024 | 748.9M CHF | 87.5M CHF | 212.9M CHF |
| 2023 | 548.5M CHF | 78.4M CHF | 155.9M CHF |
| 2022 | 497.5M CHF | 51.3M CHF | 115.9M CHF |
| 2021 | 464.8M CHF | 23.1M CHF | 92.5M CHF |
Balance sheet, profit and loss, cash flow and ratios of Ypsomed India Private Limited are on its company page.
Detailed financial statements for Ypsomed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ypsomed
4 dated milestones of Ypsomed across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Ypsomed is founded.
- Funding First funding round of $7.4M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Techmed.
Web traffic of Ypsomed
The website of Ypsomed (ypsomed.com) receives about 60.8K visits a month and ranks #618,846 among all websites worldwide, #668 in Biotechnology and Pharmaceuticals.
- Monthly visits60.8K
▲ 16.2% vs previous month
- Unique visitors23.2K
per month
- Global rank#618,846
among all websites
- Category rank#668
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit2.1
- Average visit43 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Ypsomed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| antarespharma.com | 100% | View details | |||
biochemics.com | biochemics.com | 92% | – | ||
| mercatormed.com | 84% | 2.7K | #7,691,051 | View details | |
| bioxcellence.com | 81% | 680.7K | View details | ||
kurvetech.com | kurvetech.com | 79% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 38 similar websites and full traffic analytics for Ypsomed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 38 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ypsomed
Complete news archive for Ypsomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ypsomed
Ypsomed was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Ypsomed is headquartered in Burgdorf, Switzerland. It is registered at Burgdorf, Bern, Switzerland.
Ypsomed is a funded company, having raised a total of $7.45M across 1 funding round to date. The company's 1st funding round was a Series A of $7.45M, raised on Jun 2003.
Ypsomed has 2,640 employees.
The primary company behind Ypsomed, Ypsomed India Private Limited, reported revenue of ₹15.47 Cr for FY 2025, down 5% year on year.
Ypsomed was founded in 2001 in Burgdorf, Switzerland, where injection systems for self-medication and diabetes care products are developed and manufactured. The portfolio encompasses blood glucose monitoring systems, pen needles, safety devices, and infusion systems. Operations focus on the medical device sector, supplying tools for diabetes management and self-administration across global markets.
Ypsomed offers Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump.
Yes, Ypsomed is publicly traded on SIX under the ticker symbol YPSN.
Ypsomed has 2 investors. Key investors include BV Partners, and TecMed Deutschland.
Ypsomed operates through Ypsomed India Private Limited.
Yes. Ypsomed was acquired by Techmed in April 2025.
The legal entities of Ypsomed currently have 3 directors, including Sanjay Rajpal, Jaydeep Purujit Mehta, Umeshbhai Arvindbhai Vyas.